Alzheimer's Disease Detection Through Whole-Brain 3D-CNN MRI

Frontiers in Bioengineering and Biotechnology
Guilherme FolegoAnderson Rocha

Abstract

The projected burden of dementia by Alzheimer's disease (AD) represents a looming healthcare crisis as the population of most countries grows older. Although there is currently no cure, it is possible to treat symptoms of dementia. Early diagnosis is paramount to the development and success of interventions, and neuroimaging represents one of the most promising areas for early detection of AD. We aimed to deploy advanced deep learning methods to determine whether they can extract useful AD biomarkers from structural magnetic resonance imaging (sMRI) and classify brain images into AD, mild cognitive impairment (MCI), and cognitively normal (CN) groups. We tailored and trained Convolutional Neural Networks (CNNs) on sMRIs of the brain from datasets available in online databases. Our proposed method, ADNet, was evaluated on the CADDementia challenge and outperformed several approaches in the prior art. The method's configuration with machine-learning domain adaptation, ADNet-DA, reached 52.3% accuracy. Contributions of our study include devising a deep learning system that is entirely automatic and comparatively fast, presenting competitive results without using any patient's domain-specific knowledge about the disease. We were ab...Continue Reading

References

May 4, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Susanne G MuellerLaurel Beckett
Feb 28, 2008·Journal of Magnetic Resonance Imaging : JMRI·Clifford R JackMichael W Weiner
Nov 26, 2009·Journal of Cognitive Neuroscience·Daniel S MarcusRandy L Buckner
Feb 9, 2010·Nature Reviews. Neurology·Giovanni B FrisoniPaul M Thompson
Jul 27, 2010·NeuroImage·Vladimir FonovUNKNOWN Brain Development Cooperative Group
Nov 1, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Bradley T WymanUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jan 1, 2013·NeuroImage·Ian B MaloneJonathan M Schott
Jan 11, 2014·Frontiers in Neuroinformatics·Nicholas J Tustison, Brian B Avants
Feb 6, 2015·NeuroImage·Esther E BronUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 22, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Laurel A BeckettUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Marina WeilerMassimo Filippi
Jun 6, 2016·NeuroImage·Christian WachingerUNKNOWN Australian Imaging Biomarkers and Lifestyle flagship study of ageing
Jan 26, 2017·NeuroImage. Clinical·Lauge SørensenUNKNOWN Alzheimer’s Disease Neuroimaging Initiative and the Australian Imaging Biomarkers and Lifestyle flagship study of ageing
Sep 21, 2017·Frontiers in Bioscience (Landmark Edition)·Ehsan Hosseini-AslAyman El-Baz
Apr 11, 2020·Journal of Neuroscience Methods·Anees AbrolUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
May 18, 2020·Medical Image Analysis·Junhao WenUNKNOWN Australian Imaging Biomarkers and Lifestyle flagship study of ageing
Sep 1, 2018·Machine Learning in Medical Imaging·Soheil EsmaeilzadehEhsan Adeli

❮ Previous
Next ❯

Citations

Aug 3, 2021·Computational Intelligence and Neuroscience·Morteza AminiMahshad Ouchani
Jul 7, 2021·Journal of Biomedical Informatics·Mohammed AbdelazizAhmed Elazab

❮ Previous
Next ❯

Software Mentioned

Adam
ADNet
GeForce
CUDA
SciKit
VGG
Theano
NumPy
DA
GoogLeNet

Related Concepts

Related Feeds

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.